BCWORLD PHARM. Co., Ltd. (200780.KQ)

KRW 4810.0

(0.73%)

EBITDA Summary of BCWORLD PHARM. Co., Ltd.

BCWORLD PHARM. Co., Ltd.'s latest annual EBITDA in 2023 was 14.13 Billion KRW , up 54.06% from previous year.
BCWORLD PHARM. Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 1.6 Billion KRW , up 19.53% from previous quarter.
BCWORLD PHARM. Co., Ltd. reported an annual EBITDA of 9.53 Billion KRW in 2022, up 125.32% from previous year.
BCWORLD PHARM. Co., Ltd. reported an annual EBITDA of 4.81 Billion KRW in 2021, up 30.85% from previous year.
BCWORLD PHARM. Co., Ltd. reported a quarterly EBITDA of 1.6 Billion KRW for 2024 Q2, up 19.53% from previous quarter.
BCWORLD PHARM. Co., Ltd. reported a quarterly EBITDA of 3.44 Billion KRW for 2023 Q1, down -12.23% from previous quarter.

Annual EBITDA Chart of BCWORLD PHARM. Co., Ltd. (2023 - 2015)

Historical Annual EBITDA of BCWORLD PHARM. Co., Ltd. (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	14.13 Billion KRW	54.06%
2022	9.53 Billion KRW	125.32%
2021	4.81 Billion KRW	30.85%
2020	4.12 Billion KRW	16.61%
2019	2.43 Billion KRW	-70.5%
2018	9.11 Billion KRW	-21.69%
2017	11.44 Billion KRW	32.87%
2016	8.67 Billion KRW	8.16%
2015	7.51 Billion KRW	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	1.42 Billion KRW	-51.85%
2024 Q2	1.6 Billion KRW	19.53%
2023 Q1	3.44 Billion KRW	-12.23%
2023 Q2	4.95 Billion KRW	43.97%
2023 Q3	2.67 Billion KRW	-46.0%
2023 Q4	2.98 Billion KRW	11.55%
2023 FY	- KRW	54.06%
2022 Q2	1.98 Billion KRW	-28.92%
2022 FY	- KRW	125.32%
2022 Q4	3.92 Billion KRW	802.71%
2022 Q3	434.44 Million KRW	-78.07%
2022 Q1	2.78 Billion KRW	208.52%
2021 Q1	1.85 Billion KRW	141.89%
2021 FY	- KRW	30.85%
2021 Q4	-2.56 Billion KRW	-198.44%
2021 Q3	2.6 Billion KRW	21.13%
2021 Q2	2.15 Billion KRW	16.13%
2020 Q1	1.71 Billion KRW	133.56%
2020 Q2	2.24 Billion KRW	30.44%
2020 FY	- KRW	16.61%
2020 Q4	-4.42 Billion KRW	-250.46%
2020 Q3	2.94 Billion KRW	31.38%
2019 Q4	-5.11 Billion KRW	-312.51%
2019 Q3	2.4 Billion KRW	-14.93%
2019 Q2	2.83 Billion KRW	11.76%
2019 Q1	2.53 Billion KRW	434.71%
2019 FY	- KRW	-70.5%
2018 FY	- KRW	-21.69%
2018 Q4	-756.71 Million KRW	-122.63%
2018 Q3	3.34 Billion KRW	1.03%
2018 Q2	3.31 Billion KRW	9.98%
2018 Q1	3.01 Billion KRW	-1.0%
2017 Q1	2.67 Billion KRW	0.0%
2017 FY	- KRW	32.87%
2017 Q3	2.99 Billion KRW	7.48%
2017 Q2	2.78 Billion KRW	4.23%
2017 Q4	3.04 Billion KRW	1.61%
2016 FY	- KRW	8.16%
2015 FY	- KRW	0.0%

Peer EBITDA Comparison of BCWORLD PHARM. Co., Ltd.

Name	EBITDA	EBITDA Difference
Oscotec Inc.	-30.02 Billion KRW	147.078%